| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a135a933620c99beab01d4ac785d25 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate |
1994-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6287e639ff51b183c0efdb8335c81c0f |
| publicationDate |
1996-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2131754-A1 |
| titleOfInvention |
Prostaglandin e derivatives in the treatment of dementia |
| abstract |
This invention pertains to the novel use of prostaglandin E derivatives in the treatment of dementia. A method is described of treating dementia in human beings which comprises administering to the human being a therapeutic amount of a prostaglandin E derivative, alone or in combination with antiinflammatory agents which inhibit the synthesis of prostaglandins. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0102855-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1669756-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036678-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008036678-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6596474-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1669756-A3 |
| priorityDate |
1994-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |